Barclays Cuts Revance Therapeutics (NASDAQ:RVNC) Price Target to $3.00
Revance Therapeutics (NASDAQ:RVNC – Free Report) had its price target trimmed by Barclays from $7.00 to $3.00 in a research note issued to investors on Monday,Benzinga reports. The firm currently has an equal weight rating on the biopharmaceutical company’s stock. Several other analysts have also issued reports on the stock. StockNews.com began coverage on shares […]
More Stories
Finland Launches Investigation After Another Undersea Cable Suffers Outage
By T. J. Muscaro An undersea power cable connecting Finland and Estonia called the Estlink 2 interconnector suffered an outage...
Cranswick (LON:CWK) Share Price Crosses Above Two Hundred Day Moving Average – Should You Sell?
Cranswick plc (LON:CWK – Get Free Report)’s stock price crossed above its 200-day moving average during trading on Tuesday ....
Contango Oil & Gas (NYSEAMERICAN:MCF) Share Price Crosses Above Two Hundred Day Moving Average – What’s Next?
Contango Oil & Gas (NYSEAMERICAN:MCF – Get Free Report) shares passed above its two hundred day moving average during trading...
iShares Fallen Angels USD Bond ETF (NASDAQ:FALN) Sees Strong Trading Volume – What’s Next?
Shares of iShares Fallen Angels USD Bond ETF (NASDAQ:FALN – Get Free Report) saw strong trading volume on Thursday ....
XCHG (NASDAQ:XCH) Sees Strong Trading Volume – Here’s What Happened
XCHG Limited (NASDAQ:XCH – Get Free Report) saw unusually-strong trading volume on Thursday . Approximately 617,872 shares changed hands during...
Euronav (NYSE:CMBT) Trading Down 2.7% – Here’s What Happened
Euronav NV (NYSE:CMBT – Get Free Report)’s stock price was down 2.7% during trading on Thursday . The company traded...